Results 41 to 50 of about 1,252,032 (378)

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2. [PDF]

open access: yes, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Antibody resistance dampens neutralizing antibody therapy and threatens current global Coronavirus (COVID-19) vaccine campaigns.
Gao, Zhaobing   +19 more
core   +1 more source

Cardiovascular disease in SARS‐CoV‐2 infection

open access: yesClinical & Translational Immunology, 2021
Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato   +5 more
doaj   +1 more source

The evolution of SARS-CoV-2

open access: yesNature Reviews Microbiology, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence ...
Peter V. Markov   +6 more
openaire   +2 more sources

Racing for a SARS‐CoV‐2 vaccine

open access: yesEMBO Molecular Medicine, 2021
Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj   +1 more source

Crucial contribution of the universities to SARS-CoV-2 surveillance in Ecuador: Lessons for developing countries

open access: yesOne Health, 2021
COVID-19 pandemic has challenged public health systems worldwide, particularly affecting developing countries in Latin America like Ecuador. In this report, we exposed the fundamental role of the Ecuadorian universities to improve COVID-19 surveillance ...
Daniela Santander-Gordon   +19 more
doaj  

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2

open access: yesAdvanced Science, 2020
The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong   +4 more
doaj   +1 more source

Portable real-time colorimetric LAMP-device for rapid quantitative detection of nucleic acids in crude samples

open access: yesScientific Reports, 2022
Loop-mediated isothermal amplification is known for its high sensitivity, specificity and tolerance to inhibiting-substances. In this work, we developed a device for performing real-time colorimetric LAMP combining the accuracy of lab-based quantitative ...
G. Papadakis   +17 more
doaj   +1 more source

Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil

open access: yesFrontiers in Microbiology, 2021
A previous study demonstrates that most of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Brazilian strains fell in three local clades that were introduced from Europe around late February 2020.
Paola Cristina Resende   +29 more
doaj   +1 more source

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS‐CoV‐2.
Jin-Jin Zhang   +7 more
semanticscholar   +1 more source

Diagnosis and Management of COVID-19 Disease [PDF]

open access: yes, 2020
SARS-CoV-2 is a novel coronavirus that was identified in late 2019 as the causative agent of COVID-19 (aka coronavirus disease 2019). On March 11, 2020, the World Health Organization (WHO) declared the world-wide outbreak of COVID-19 a pandemic.
Carlos, Graham   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy